Fierce Pharma publisher Rebecca Willumson caught up with ixlayer’s General Manager of Biopharma, Matthew Walsh, at Digital Pharma East 2024 for a quick interview about the current and future state of pharma marketing.
Recap: Peer-to-Peer Lunch at Fierce Pharma Week – Building Direct-to-Patient Programs That Work At this
New ixlayer Survey Finds 73% of Pharma Leaders Are Running or Planning to Launch a
Compliance Considerations for Direct-to-Patient Programs: What Pharma Needs in a Trusted Partner By Pouria Sanae,
IXLAYER TAKES “HEALTHCARE TECHNOLOGY INNOVATION OF THE YEAR” IN THE 2025 STEVIE AWARDS FOR TECHNOLOGY
Recap: Peer-to-Peer Lunch at Fierce Pharma Week – Building Direct-to-Patient Programs That Work At this year’s Fierce Pharma Week, ixlayer
New ixlayer Survey Finds 73% of Pharma Leaders Are Running or Planning to Launch a DTP Program in the Next
Compliance Considerations for Direct-to-Patient Programs: What Pharma Needs in a Trusted Partner By Pouria Sanae, CEO, ixlayer As biopharma companies
